Lincoln Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	823.46	933.05	728.99	693.55	622.5
Depreciation & Amortization	127.98	105.19	90.55	79.53	74.22
Other Amortization	1.01	1.06	1.11	1.35	1.38
Loss (Gain) From Sale of Assets	1.4	2.76	-0.76	1.3	0.53
Loss (Gain) From Sale of Investments	-61.2	-227.85	-51.35	-36.1	-24.5
Provision & Write-off of Bad Debts	1.49	6.5	-1.78	5.27	0.91
Other Operating Activities	-55.69	-27.36	-60.42	-7.61	15.62
Change in Accounts Receivable	-47.79	-260.86	-202.12	-31.19	-100.83
Change in Inventory	-15.09	-71.4	27.14	-261.29	7.83
Change in Accounts Payable	125.08	215.73	-205.14	145.93	55.5
Change in Other Net Operating Assets	29.5	-44.64	66.39	170.6	39.54
Operating Cash Flow	930.16	632.17	392.62	761.32	692.7
Operating Cash Flow Growth	47.14%	61.01%	-48.43%	9.91%	-8.15%
Capital Expenditures	-190.29	-394.76	-142.59	-455.25	-87.5
Sale of Property, Plant & Equipment	1.22	0.9	7.06	0.79	0.65
Divestitures	-	-	-	-	0.5
Sale (Purchase) of Intangibles	-2.15	-1.37	-0.23	-	-
Investment in Securities	-286.83	-248.05	106.14	-125.3	-439.99
Other Investing Activities	25.38	305.48	-140.95	-81.26	16.15
Investing Cash Flow	-789.47	-573.41	-366.43	-780.8	-642.27
Short-Term Debt Issued	684.2	200	193.57	20	-
Total Debt Issued	684.2	200	193.57	20	-
Short-Term Debt Repaid	-694.17	-209.02	-195.02	-	-38.33
Long-Term Debt Repaid	-	-	-	-5.2	-7.21
Total Debt Repaid	-694.17	-209.02	-195.02	-5.2	-45.54
Net Debt Issued (Repaid)	-9.97	-9.02	-1.44	14.8	-45.54
Common Dividends Paid	-36.05	-30.05	-30.05	-30	-
Other Financing Activities	-17.99	-12.74	-13.52	-10.36	-11.91
Financing Cash Flow	-64.02	-51.8	-45.01	-25.56	-57.45
Net Cash Flow	76.67	6.95	-18.82	-45.04	-7.03
Free Cash Flow	739.86	237.41	250.03	306.07	605.19
Free Cash Flow Growth	211.64%	-5.05%	-18.31%	-49.43%	-10.64%
Free Cash Flow Margin	11.87%	4.09%	4.90%	6.48%	14.27%
Free Cash Flow Per Share	36.94	11.85	12.48	15.28	30.21
Cash Interest Paid	17.99	12.74	13.52	10.36	11.91
Cash Income Tax Paid	263.07	261.51	296.1	236.96	194.91
Levered Free Cash Flow	452.3	213.14	44.59	62.93	493.48
Unlevered Free Cash Flow	458.52	219.05	54.82	68.68	500.99
Change in Working Capital	91.71	-161.17	-313.74	24.05	2.04

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.